CL Educate Limited

NSEI:CLEDUCATE Lagerbericht

Marktkapitalisierung: ₹4.7b

CL Educate Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für CL Educate zu prognostizieren.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Consumer Services Gewinnwachstum19.9%
Wachstumsrate der Einnahmenn/a
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

None

Zuletzt aktualisiertn/a

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Returns On Capital Signal Difficult Times Ahead For CL Educate (NSE:CLEDUCATE)

Jun 11
Returns On Capital Signal Difficult Times Ahead For CL Educate (NSE:CLEDUCATE)

CL Educate (NSE:CLEDUCATE) Has Some Difficulty Using Its Capital Effectively

Feb 10
CL Educate (NSE:CLEDUCATE) Has Some Difficulty Using Its Capital Effectively

Returns On Capital Are Showing Encouraging Signs At CL Educate (NSE:CLEDUCATE)

Oct 19
Returns On Capital Are Showing Encouraging Signs At CL Educate (NSE:CLEDUCATE)

CL Educate (NSE:CLEDUCATE) Has Some Way To Go To Become A Multi-Bagger

Mar 30
CL Educate (NSE:CLEDUCATE) Has Some Way To Go To Become A Multi-Bagger

Returns On Capital Signal Difficult Times Ahead For CL Educate (NSE:CLEDUCATE)

Oct 27
Returns On Capital Signal Difficult Times Ahead For CL Educate (NSE:CLEDUCATE)

Does CL Educate (NSE:CLEDUCATE) Have A Healthy Balance Sheet?

Aug 02
Does CL Educate (NSE:CLEDUCATE) Have A Healthy Balance Sheet?

CL Educate (NSE:CLEDUCATE) Could Be Struggling To Allocate Capital

Jun 02
CL Educate (NSE:CLEDUCATE) Could Be Struggling To Allocate Capital

CL Educate (NSE:CLEDUCATE) Has Debt But No Earnings; Should You Worry?

Feb 07
CL Educate (NSE:CLEDUCATE) Has Debt But No Earnings; Should You Worry?

We Think Shareholders May Want To Consider A Review Of CL Educate Limited's (NSE:CLEDUCATE) CEO Compensation Package

Aug 31
We Think Shareholders May Want To Consider A Review Of CL Educate Limited's (NSE:CLEDUCATE) CEO Compensation Package

The Founder & Chairman of CL Educate Limited (NSE:CLEDUCATE), Satya Ramakrishnan, Just Bought A Few More Shares

Mar 21
The Founder & Chairman of CL Educate Limited (NSE:CLEDUCATE), Satya Ramakrishnan, Just Bought A Few More Shares

Is CL Educate (NSE:CLEDUCATE) Using Debt In A Risky Way?

Mar 14
Is CL Educate (NSE:CLEDUCATE) Using Debt In A Risky Way?

Should You Buy CL Educate Limited (NSE:CLEDUCATE) For Its Dividend?

Feb 07
Should You Buy CL Educate Limited (NSE:CLEDUCATE) For Its Dividend?

Insider Buying: The CL Educate Limited (NSE:CLEDUCATE) Founder & Chairman Just Bought ₹70k Worth Of Shares

Dec 19
Insider Buying: The CL Educate Limited (NSE:CLEDUCATE) Founder & Chairman Just Bought ₹70k Worth Of Shares

Health Check: How Prudently Does CL Educate (NSE:CLEDUCATE) Use Debt?

Dec 13
Health Check: How Prudently Does CL Educate (NSE:CLEDUCATE) Use Debt?

Factors Income Investors Should Consider Before Adding CL Educate Limited (NSE:CLEDUCATE) To Their Portfolio

Nov 08
Factors Income Investors Should Consider Before Adding CL Educate Limited (NSE:CLEDUCATE) To Their Portfolio

Vice Chairman & MD Gautam Puri Just Bought A Handful Of Shares In CL Educate Limited (NSE:CLEDUCATE)

Sep 02
Vice Chairman & MD Gautam Puri Just Bought A Handful Of Shares In CL Educate Limited (NSE:CLEDUCATE)

Consider This Before Buying CL Educate Limited (NSE:CLEDUCATE) For The 2.6% Dividend

Aug 10
Consider This Before Buying CL Educate Limited (NSE:CLEDUCATE) For The 2.6% Dividend

Have Insiders Been Buying CL Educate Limited (NSE:CLEDUCATE) Shares?

Jul 07
Have Insiders Been Buying CL Educate Limited (NSE:CLEDUCATE) Shares?

In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da CL Educate jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.

Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.

Gewinn- und Umsatzwachstumsprognosen

NSEI:CLEDUCATE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (INR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
3/31/20243,18615137256N/A
12/31/20233,130161N/AN/AN/A
9/30/20233,112172-21219N/A
6/30/20233,117162N/AN/AN/A
3/31/20232,913225-40243N/A
12/31/20222,748249N/AN/AN/A
9/30/20222,614241-35239N/A
6/30/20222,252224N/AN/AN/A
3/31/20222,092139124334N/A
12/31/20212,010-25N/AN/AN/A
9/30/20211,968-6118121N/A
6/30/20211,893-105N/AN/AN/A
3/31/20211,823-126211261N/A
12/31/20201,930-633N/AN/AN/A
9/30/20202,137-636185275N/A
6/30/20202,694-579N/AN/AN/A
3/31/20203,088-543169295N/A
12/31/20193,356113N/AN/AN/A
9/30/20193,38416389205N/A
6/30/20193,384182N/AN/AN/A
3/31/20193,39517790165N/A
12/31/20183,379131N/AN/AN/A
9/30/20183,33474N/AN/AN/A
6/30/20183,03055N/AN/AN/A
3/31/20182,88932-1,456-1,257N/A
12/31/20172,842136N/AN/AN/A
9/30/20172,678127N/AN/AN/A
6/30/20172,718151N/AN/AN/A
3/31/20172,633138N/A1,290N/A
12/31/20162,486112N/AN/AN/A
9/30/20162,777234N/A97N/A
6/30/20162,659173N/AN/AN/A
3/31/20162,739190N/A49N/A
3/31/20152,735212N/A204N/A
3/31/20142,186153N/A98N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von CLEDUCATE über der Sparquote liegt (6.7%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von CLEDUCATE schneller wachsen werden als der Markt Indian

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CLEDUCATE in den nächsten 3 Jahren signifikant steigen werden.

Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CLEDUCATE schneller wachsen werden als der Markt von Indian.

Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von CLEDUCATE schneller wachsen werden als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CLEDUCATE in 3 Jahren voraussichtlich hoch sein wird

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y